The effect of synbiotic on the status of indices of anemia in women

The effect of synbiotic capsule on the status of hematologic indices of anemia in women with iron deficiency anemia referring to in City Level Labs Mahallat

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190807044465N1

Enrollment

Registered

2019-10-26

Start date

2019-10-23

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron deficiency anemia. Iron deficiency anemia

Interventions

Intervention group: Women 20-35 years old with iron deficiency anemia/ Synbiotic supplement as Familact capsule contains high levels (109 CFU) of different probiotics prescribed in doses of 500 mg / 2

Eligibility

Sex/Gender

Female

Age

20 Years to 35 Years

Inclusion criteria

Inclusion criteria: Women with iron deficiency anemia referred to in City Level Labs Mahallat

Exclusion criteria

Exclusion criteria: Women under 20 and over 35 years

Design outcomes

Primary

Measure	Time frame
RBC index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Biochemical test.;HB index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Biochemical test.;HCT index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Biochemical test.;MCV index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Biochemical test.;MCH index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Biochemical test.;MCHC index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Biochemical test.;RDW index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Biochemical test.;Ferritin index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Biochemical test.;IRON index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Biochemical test.;TIBC index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Biochemical test.;BMI index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Balance and meter.	—

Measure

Time frame

RBC index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Biochemical test.;HB index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Biochemical test.;HCT index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Biochemical test.;MCV index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Biochemical test.;MCH index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Biochemical test.;MCHC index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Biochemical test.;RDW index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Biochemical test.;Ferritin index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Biochemical test.;IRON index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Biochemical test.;TIBC index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Biochemical test.;BMI index. Timepoint: Baseline - 12 weeks after intervention. Method of measurement: Balance and meter.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoudabeh Amiri

Arak University of Medical Sciences

sodabehamiry@yahoo.com+98 86 4322 3026

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026